CERENIS THERAPEUTICS Quotes Cerenis Therapeutics LIQUIDNET SYSTEMS
Equities
FR0012616852
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | -.--% |
| Mar. 14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
| Mar. 11 | Abionyx: reduced net loss in 2023 | CF |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
40 258 626
Capitalization (USD)
43 753 477
Net sales (EUR)
4 600 000
Net sales (USD)
4 999 326
Free-Float
68.01 %
Free-Float capitalization (EUR)
27 596 919
Free-Float capitalization (USD)
29 992 608
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 43.75M | ||
| +0.05% | +5.24% | +15.59% | +40.63% | 121B | ||
| +0.74% | +2.66% | +13.74% | +33.15% | 107B | ||
| -1.99% | +8.10% | -3.62% | -6.45% | 24.82B | ||
| +0.43% | +3.32% | +1.57% | -6.79% | 22.48B | ||
| -0.44% | +0.52% | -9.77% | -29.11% | 18.32B | ||
| -0.26% | -0.99% | -42.28% | -38.09% | 16.33B | ||
| +3.62% | -1.03% | -15.98% | -31.69% | 15.31B | ||
| -2.33% | -2.21% | +4.27% | +46.37% | 14.08B | ||
| -2.39% | +7.72% | +26.60% | -3.24% | 11.74B | ||
| -0.07% | +14.34% | +77.32% | +182.23% | 9.02B | ||
| -0.53% | +5.20% | +15.09% | +41.94% | 7.85B | ||
| -0.37% | +6.18% | +7.34% | +47.15% | 7.76B | ||
| +0.90% | -0.12% | -3.42% | +24.85% | 7.4B | ||
| +2.34% | -2.03% | -32.13% | -37.48% | 7.3B | ||
| -8.27% | -11.41% | +211.12% | +150.98% | 6.87B | ||
| Average | -0.54% | +10.94% | +17.70% | +27.63% | ||
| Weighted average by Cap. | -0.04% | +4.87% | +11.64% | +26.22% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
- Stock Market
- Equities
- ABNX Stock
- Stock
- Quotes Cerenis Therapeutics
